ING Groep NV Lowers Stock Position in Colgate-Palmolive (NYSE:CL)

ING Groep NV lessened its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 104,399 shares of the company’s stock after selling 4,928 shares during the quarter. ING Groep NV’s holdings in Colgate-Palmolive were worth $9,491,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in CL. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $32,000. Hager Investment Management Services LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $36,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Roxbury Financial LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $43,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $53,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.9 %

Shares of NYSE CL opened at $89.56 on Friday. Colgate-Palmolive has a 52-week low of $84.45 and a 52-week high of $109.30. The firm has a fifty day moving average of $88.94 and a 200-day moving average of $95.91. The stock has a market capitalization of $72.68 billion, a PE ratio of 25.44, a P/E/G ratio of 4.18 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. On average, analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Wall Street Analyst Weigh In

CL has been the subject of a number of research reports. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $101.16.

Read Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.